190 related articles for article (PubMed ID: 3306380)
1. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam.
Greenblatt DJ; Harmatz JS; Zinny MA; Shader RI
N Engl J Med; 1987 Sep; 317(12):722-8. PubMed ID: 3306380
[TBL] [Abstract][Full Text] [Related]
2. Rebound insomnia: duration of use and individual differences.
Merlotti L; Roehrs T; Zorick F; Roth T
J Clin Psychopharmacol; 1991 Dec; 11(6):368-73. PubMed ID: 1770156
[TBL] [Abstract][Full Text] [Related]
3. Rebound insomnia: a critical review.
Gillin JC; Spinweber CL; Johnson LC
J Clin Psychopharmacol; 1989 Jun; 9(3):161-72. PubMed ID: 2567741
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the short-acting benzodiazepines midazolam and triazolam with placebo.
Hegelbach-Feller DA; Tschopp JM; Christeller S; Fabre J
Arzneimittelforschung; 1988 Mar; 38(3):387-92. PubMed ID: 3289550
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of an every-other-night regimen in insomniac patients: subjective hypnotic effectiveness of quazepam, triazolam, and placebo.
Scharf MB
J Clin Psychiatry; 1993 Jan; 54(1):33-8. PubMed ID: 8428895
[TBL] [Abstract][Full Text] [Related]
6. Rebound insomnia in normals and patients with insomnia after abrupt and tapered discontinuation.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1992; 108(1-2):67-71. PubMed ID: 1410148
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia.
Fleming JA; McClure DJ; Mayes C; Phillips R; Bourgouin J
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():29-37. PubMed ID: 2201728
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs.
Elie R; Frenay M; Le Morvan P; Bourgouin J
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():39-46. PubMed ID: 2201729
[TBL] [Abstract][Full Text] [Related]
9. Comparative hypnotic effects of flurazepam, triazolam, and placebo: a long-term simultaneous nighttime and daytime study.
Mitler MM; Seidel WF; van den Hoed J; Greenblatt DJ; Dement WC
J Clin Psychopharmacol; 1984 Feb; 4(1):2-13. PubMed ID: 6141188
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
11. Polysomnography during withdrawal with clomethiazole or placebo in alcohol dependent patients--a double-blind and randomized study.
Gann H; Feige B; Cloot O; Van Wasen H; Zinzgraf D; Hohagen F; Riemann D
Pharmacopsychiatry; 2004 Sep; 37(5):228-35. PubMed ID: 15359376
[TBL] [Abstract][Full Text] [Related]
12. Multi-clinic double-blind comparison of triazolam (Halcion) and placebo administered for 14 consecutive nights in outpatients with insomnia.
Fabre LF; Brachfeld J; Meyer LR; Slowe IA; Calvo R; Metzler C
J Clin Psychiatry; 1978 Aug; 39(8):679-82. PubMed ID: 28313
[TBL] [Abstract][Full Text] [Related]
13. Nighttime versus daytime hypnotic self-administration.
Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
[TBL] [Abstract][Full Text] [Related]
14. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone.
Mouret J; Ruel D; Maillard F; Bianchi M
Int Clin Psychopharmacol; 1990 Apr; 5 Suppl 2():47-55. PubMed ID: 2201730
[TBL] [Abstract][Full Text] [Related]
15. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
16. [Triazolam 0.25 mg versus loprazolam 1 mg in the treatment of common insomnia treated in general practice. Double-blind cross-over randomized trial].
Bourin M; André-David F
Therapie; 1989; 44(2):107-14. PubMed ID: 2569239
[TBL] [Abstract][Full Text] [Related]
17. Clonazepam: sleep laboratory study of efficacy and withdrawal.
Kales A; Manfredi RL; Vgontzas AN; Baldassano CF; Kostakos K; Kales JD
J Clin Psychopharmacol; 1991 Jun; 11(3):189-93. PubMed ID: 2066457
[TBL] [Abstract][Full Text] [Related]
18. Profile of mood states changes during and after 5 weeks of nightly triazolam administration.
Bliwise DL; Seidel WF; Cohen SA; Bliwise NG; Dement WC
J Clin Psychiatry; 1988 Sep; 49(9):349-55. PubMed ID: 3047100
[TBL] [Abstract][Full Text] [Related]
19. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
Small GW; Bystritsky A
J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
[TBL] [Abstract][Full Text] [Related]
20. Quazepam versus triazolam in patients with sleep disorders: a double-blind study.
Mauri MC; Gianetti S; Pugnetti L; Altamura AC
Int J Clin Pharmacol Res; 1993; 13(3):173-7. PubMed ID: 7901174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
